Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. The company is headquartered in Houston, Texas. Show more

RIVER OAKS TOWER, HOUSTON, TX, UNITED STATES, 77098, 3730 Kirby Drive, Suite 1200, Texas, 77098, USA

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

2.95M

52 Wk Range

$0.00 - $0.00

Previous Close

$0.04

Open

$0.04

Volume

N/A

Day Range

$0.04 - $0.04

Enterprise Value

0.00

Cash

8.535M

Avg Qtr Burn

-9.808M

Insider Ownership

38.69%

Institutional Own.

8.21%

Qtr Updated

09/30/23

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Batiraxcept (AVB-500) Details Renal cell carcinoma	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Batiraxcept (AVB-500) Details Pancreatic cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Batiraxcept (AVB-500) Details Solid tumor/s, Cancer, Ovarian cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Batiraxcept (AVB-500) Details Solid tumor/s, Cancer, Renal cell carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.